Mayo Clinic researchers have developed a method to reduce the production of alpha-synuclein in the brain. Alpha-synuclein is a protein that is believed to be central to the cause of Parkinson’s disease. All patients with Parkinson’s disease have abnormal accumulations of alpha-synuclein protein in the brain.
The new method involves the delivery of RNA interference compounds [...]
-
Links
-
Mayo Clinic Photos on Flickr
More Photos
